Healthcare Stocks Fall as Market Rout Spreads

A facts-only brief, written by a local AI model from this article in The Wall Street Journal, November 6, 2026. It may contain mistakes, and it is not the article: the full story is at wsj.com.

Global healthcare equities declined on Friday as a broad market sell-off extended to European and Asian trading sessions following earlier losses in U.S. and AI-related sectors. In U.S. premarket trading, major pharmaceutical firms including Eli Lilly, Johnson & Johnson, AbbVie, and Merck all traded more than 1% lower. European markets saw sharper drops, with the Stoxx Europe 600 Health Care index falling 2.9% by midday, outpacing the 1.8% decline of the broader Stoxx Europe 600. Japanese pharmaceutical stocks experienced significant losses, with Takeda and Chugai closing down approximately 5%, while smaller competitors Daiichi Sankyo and Astellas Pharma fell 10% and 7.5%, respectively.

Background

• Susannah Streeter of Wealth Club suggested investors may be realizing gains in healthcare to offset losses in other portfolio areas.
• Ipek Ozkardeskaya of Swissquote noted that the risk-off sentiment is pressuring even defensive market sectors.
• RBC Capital Markets analysts warned that recent sector gains had led to stretched valuations, increasing vulnerability to a pullback if market focus returns to growth and technology stocks.

Read the full article at wsj.com

More from Friday, November 6: